Blog

Aren Karapetyan: Latest findings from Ontario revealing dynamic shifts in the management of Stage I NSCLC

Photo taken from www.thegreenjournal.com

May 3, 2024, 22:20

Aren Karapetyan: Latest findings from Ontario revealing dynamic shifts in the management of Stage I NSCLC

Aren Karapetyan, Medical Resident at Yerevan State Medical University named after Mkhitar Heratsi and Secretary at the shared a post on LinkedIn:

“Delve into the latest findings from Ontario, Canada, revealing dynamic shifts in the management of Stage I NSCLC from 2010 to 2019. Stereotactic Ablative Body Radiotherapy, particularly Stereotactic Ablative Body Radiotherapy (SABR), is becoming increasingly popular, with more patients opting for it and experiencing better survival rates. Meanwhile, surgical methods are on the decline, indicating a significant change in how lung cancer is treated.”

Additional information.
Source: Aren Karapetyan/LinkedIn

Aren Karapetyan Canada cancer dynamic shifts lung cancer treatment management trends Medical Research non small cell lung cancer OncoDaily Oncology Ontario SABR stage I NSCLC stereotactic ablative body radiotherapy surgical methods survival rates

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity